SCHEMBL6570706

SCHEMBL6570706

CS(=O)(=O)c1sc(N)nc1C(N)=O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.37
CYP1A2 P05177 1/20 0.37
KDM4E B2RXH2 3/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
HPGD P15428 1/20 0.33
HSD17B10 Q99714 1/20 0.33
PDPK1 O15530 1/20 0.33
CCNC P24863 1/20 0.33
CDK8 P49336 1/20 0.33
CDK19 Q9BWU1 1/20 0.33
LMNA P02545 1/20 0.33
MAPK1 P28482 1/20 0.33
LRRK2 Q5S007 1/20 0.32
PKM P14618 2/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
MAPT P10636 1/20 0.32
IKBKB O14920 1/20 0.32
CCNA2 P20248 1/20 0.31
CDK2 P24941 1/20 0.31
COPS5 Q92905 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9273968 0.72 MAPT (0.36) ALDH1A1KDM4ESMN1; SMN2HPGDHSD17B10
SCHEMBL27558227 0.72 NOS1 (0.48) ALDH1A1CYP1A2KDM4ESMN1; SMN2HPGD
SCHEMBL27886757 0.71 PDPK1 (0.40) ALDH1A1CYP1A2KDM4ESMN1; SMN2HPGD
SCHEMBL6570704 0.70 PDPK1 (0.33) PDPK1LRRK2IKBKB
SCHEMBL26851680 0.68 COPS5 (0.38) ALDH1A1CYP1A2KDM4ESMN1; SMN2HPGD
SCHEMBL15652654 0.68 COPS5 (0.44) ALDH1A1CYP1A2KDM4ESMN1; SMN2HPGD
SCHEMBL13301114 0.66 ALDH1A1 (0.36) ALDH1A1CYP1A2KDM4ESMN1; SMN2HPGD
SCHEMBL6630014 0.63 FBP1 (0.36) PDPK1LRRK2IKBKBFBP1JAK2
SCHEMBL6630011 0.63 IKBKB (0.45) PDPK1IKBKBJAK2JAK1TYK2
SCHEMBL4102262 0.63 NOS1 (0.46) ALDH1A1CYP1A2SMN1; SMN2HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1404664-A1 AMINEDIOLS FOR THE TREATMENT OF ALZHEIMER'S DISEASE Elan Pharmaceuticals, Inc. (US) 2004-04-07 EP claimed
WO-2003006453-A1 AMINEDIOLS FOR THE TREATMENT OF ALZHEIMER'S DISEASE ELAN PHARMACEUTICALS, INC. (US) 2003-01-23 WO claimed
EP-1406617-A1 DIAMINEDIOLS FOR THE TREATMENT OF ALZHEIMER'S DISEASE Elan Pharmaceuticals, Inc. (US) 2004-04-14 EP disclosed
EP-1404664-A1 AMINEDIOLS FOR THE TREATMENT OF ALZHEIMER'S DISEASE Elan Pharmaceuticals, Inc. (US) 2004-04-07 EP disclosed
EP-1395251-A2 AMINEDIOLS AS AGENTS FOR THE TREATMENT OF ALZHEIMER'S DISEASE Elan Pharmaceuticals, Inc. (US) 2004-03-10 EP disclosed
WO-2003006013-A1 DIAMINEDIOLS FOR THE TREATMENT OF ALZHEIMER'S DISEASE ELAN PHARMACEUTICALS, INC. (US) 2003-01-23 WO disclosed
WO-2003006453-A1 AMINEDIOLS FOR THE TREATMENT OF ALZHEIMER'S DISEASE ELAN PHARMACEUTICALS, INC. (US) 2003-01-23 WO disclosed
WO-2002100818-A2 AMINEDIOLS AS AGENTS FOR THE TREATMENT OF ALZHEIMER'S DISEASE ELAN PHARMACEUTICALS, INC. (US) 2002-12-19 WO disclosed